2025 International Congress Archives - Page 173 of 181

Understanding the relationship between synaptic density and dopamine transporter availability in Parkinson’s disease

F. Ebrahimian Sadabad, T. Volpi, P. Honhar, S. Tinaz, M. Dias, T. Toyonaga, M. Naganawa, J. Gallezot, Y. Yang, W. Ibrahim, S. Cayir, R. Radhakrishnan, G. Angarita, S. Holmes, R. Comley, R. Carson, S. Finnema, D. Matuskey (New Haven, USA)
Undescribed Variant of the THAP1 Gene Likely Pathogenic Associated with DYT6 – Case Report

J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, D. Dos Santos, C. Habekost, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)
Unilateral focused ultrasound subthalamotomy in early Parkinson’s disease: randomized-controlled trial protocol

R. Martinez-Fernandez, MC. Rodriguez Oroz, S. Paschen, C. Juri, M. Del Alamo, E. Natera-Villalba, R. Rodriguez-Rojas, LH. Gonzalez-Quarante, M. Synowitz, J. Lorenzoni, CA. Sánchez-Catasús, S. Obika, T. Jimenez-Castellanos, P. Reiters, E. Cerutti, RA. Villino-Boquete, C. Ferrer, O. Rascol, G. Deuschl, JA. Obeso (Madrid, Spain)
Unmasking Wilson Disease: Subacute Neurological Complications During the COVID-19 Pandemic

BY. Chen (Tainan, Taiwan)
Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)
Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)
Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)
Unraveling the Estrogen-Parkinson’s Disease Link: Methodological Challenges in Meta-Analyzing Reproductive Factors and PD Risk.

EP. Papathoma, TN. Ntetsika, TS. Soumala, IM. Markaki (Solna, Sweden)
Unraveling the Genetic Architecture of Progressive Supranuclear Palsy in East Asians

P. Chen, R. Lin, N. Lee, J. Hsu, C. Tai, R. Wu, H. Chiang, Y. Wu, C. Lu, H. Chang, T. Lee, Y. Chang, C. Lin (Taipei, Taiwan)
Unraveling the Intertwined Relationship of DBS, Parkinson’s Disease Subtype and LEDD: A Retrospective Study

T. Mehta, V. Lavu, C. Hess, A. Ramirez-Zamora, M. Okun, J. Wong (Gainesville, USA)